文献速递甲状腺疾病

欧洲癌症研究与治疗组织甲状腺癌模块EORTC QLQ-THY34信效度国际IV期现场研究

International Phase IV Field Study for the Reliability and Validity of the European Organisation for Research and Treatment of Cancer Thyroid Cancer Module EORTC QLQ-THY34.
PubMed 文献 · Thyroid · 2023-08-09

本研究纳入17个国家437例甲状腺癌患者,验证EORTC QLQ-THY34生活质量模块。全部34个条目均保留,9个多条目量表中8个Cronbach's α>0.70,所有标准化因子载荷>0.40,所有量表ICC>0.70。结论认为该模块是可靠有效的甲状腺癌生活质量测量工具。

要点

  • 全部34个条目均符合保留标准,问卷包含9个多条目量表和8个单条目量表。
  • 9个多条目量表中8个Cronbach's α>0.70,所有标准化因子载荷>0.40,验证了量表结构。
  • 所有量表ICC>0.70,重测信度良好;不同组织学类型患者间量表得分差异均>5分。

核心结论

  • EORTC QLQ-THY34包含9个多条目量表和8个单条目量表,是测量甲状腺癌患者生活质量的可靠有效工具,可用于未来试验和研究。

研究设计与样本

  • 国际IV期现场研究,纳入17个国家的437例甲状腺癌患者。
  • 第一组303例正在接受治疗或最佳支持治疗,在三个时间点完成问卷:治疗前(t1)、6周后(t2)和t2后6个月(t3)。
  • 第二组134例为诊断后≥2年的生存者,在随机基线时间点完成问卷,并于1周后第二次完成。
  • 采用Cronbach's α评估内部一致性,验证性因子分析评估量表结构,已知组比较评估判别效度,第一组数据评估反应度,第二组数据通过组内相关系数(ICC)确定重测信度。

主要发现

  • 全部34个条目均符合保留标准。
  • Cronbach's α在9个多条目量表中有8个>0.70。
  • 所有标准化因子载荷均>0.40,确认了所提出的量表结构。
  • 所有量表的ICC均>0.70,重测信度良好。
  • 不同组织学类型患者间量表得分差异在所有量表中均>5分;除口干(Dry Mouth)外,所有预先指定量表在至少两个时间点间的变化≥|4|分。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Purpose: The aim of this study was to validate the new European Organisation for Research and Treatment of Cancer Quality of Life Thyroid Cancer Module (EORTC QLQ-THY34). Methods: We enrolled 437 thyroid cancer patients from 17 countries. One group (n = 303), undergoing treatment or best supportive care, completed the questionnaires at three time points (before therapy [t1], 6 weeks later [t2], and 6 months after t2 [t3]). A second group (survivors ≥2 years after diagnosis, n = 134) completed it at a random baseline time point and a second time 1 week later. We determined internal consistency (using Cronbach's alpha), the scale structure (with confirmatory factor analysis), and discriminant validity (using known-group comparisons). Group 1 data were used to assess responsiveness and group 2 data to determine test-retest reliability using intra-class correlations (ICC). Results: All 34 items fulfilled the criteria to be kept in the questionnaire. Cronbach's alpha was >0.70 in 8 of the 9 multi-item scales. All standardized factor loadings exceeded 0.40, confirming the proposed scale structure. The ICC was >0.70 in all scales expressing good test-retest reliability. Differences in scale scores between patients with different histology were >5 points in all scales. In all but one of the pre-specified scales (Dry Mouth), changes over time were ≥|4| points between at least two time points. Conclusion: The EORTC QLQ-THY34 with its 9 multi-item and 8 single-item scales is a reliable and valid tool to measure quality of life in thyroid cancer patients and can be used in future trials and studies.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Singer S, Al-Ibraheem A, Pinto M, et al. International Phase IV Field Study for the Reliability and Validity of the European Organisation for Research and Treatment of Cancer Thyroid Cancer Module EORTC QLQ-THY34. Thyroid. 2023. PMID: 37450344. doi:10.1089/thy.2023.0221

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。